Meet an IMDA Member - OE Meyer Co
president sales and marketing
OE Meyer is an anesthesia/respiratory specialty dealer
focused on helping our customers navigate the complex healthcare
landscape and address product fulfillment needs and services.
Doing what's right has resulted in long-standing customer
relationships and satisfaction.
In today's environment of healthcare supplier consolidation, it
can be frustrating when suppliers seem more focused on internal
interests than on you. OE Meyer Co. is a diverse team of problem
solvers that deliver continuity of service, expertise, and
consistent representation. We'll be there when you need
convenient, cost-effective, and comprehensive solutions.
Here's what you can expect from OE Meyer Co.:
Professionally trained employee owners.
Same day shipping for orders placed by 3:00 p.m. EST.
99 percent of established product orders ship same day.
Customer-based shipping preferences. Dedicated OE Meyer Co.
drivers can deliver to many customer locations, or within
1-2 days via common carrier.
Product samples: Just askâ€¦we can help.
No-hassle return policy.
Cybersecurity bill introduced. A bill to create a public-private
partnership to lay out a cybersecurity framework was introduced
by U.S. Reps. Dave Trott and Susan Brooks. â€œBad actors are not
only looking to access sensitive information, but they are also
trying to manipulate device functionality,â€ said Rep. Brooks,
referring to The Internet of Medical Things Resilience
Partnership Act. â€œThis can lead to life-threatening
cyber-attacks on devices ranging from monitors and infusion
pumps, to ventilators and radiological technologies. As the
number of connected medical devices continue to grow, so does
the urgency to establish guidelines for how to prevent these
kinds of dangerous attacks.â€
Medical technology: Looking good. Medical technology
innovation continues to drive growth, according to EYâ€™s Pulse of
the Industry 2017 report, released at the annual conference of
AdvaMed. In 2016, the U.S. Food & Drug Administration approved
39 new class III medical devices via its pre-market approval
(PMA) pathway, reports EY. As of July 31, 2017, there were 26
PMA approvals, putting the industry on track to nearly rival the
approval numbers last achieved in 2004. The uptick in approvals
that began in 2015 suggests that medtechs are beginning to adapt
to higher regulatory and reimbursement thresholds and are
investing proactively in safety and efficacy studies to better
demonstrate the utility of their devices.
Public/private partnership for medical devices. Mayo Clinic
and Boston Scientific have jointly filed a patent application
for a catheter designed to allow heart surgeons to become more
efficient when performing aortic valve replacements, reports
Twin Cities Business. The development is part of an intellectual
property collaboration announced between the two last year.
Called a self-centering guide catheter, the device is meant to
help surgeons efficiently thread a guidewire through a narrowed
aortic valve opening in a heart affected by calcification. It is
being developed by a team led by Mayo cardiologist Dr. Gurpreet
Sandhu and Boston Scientific research fellow Roger McGowan.
Bundling programs outlook uncertain. Hospitals generally
support the proposed cancellation of the cardiac and Surgical
Hip and Femur Fracture Treatment bundling program and
Comprehensive Care for Joint Replacement bundling program, and
partial conversion of the CJR program to a voluntary model,
American Hospital Association Executive Vice President Tom
Nickels told the Centers for Medicare & Medicaid Services in
comments submitted to CMS Oct. 10. However, some hospitals have
concerns, leading AHA to urge CMS to â€œexpeditiously pursue the
creation of new, voluntary advanced [alternative payment models]
that would allow hospitals to not only capitalize on the work
many of them already have done to prepare for such models, but
also partner with clinicians to provide better, more efficient